NVAX - Novavax - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

NVAX is currently covered by 5 analysts with an average price target of $14.5. This is a potential upside of $7.03 (94.11%) from yesterday's end of day stock price of $7.47.

Novavax's activity chart (see below) currently has 243 price targets and 204 ratings on display. The stock rating distribution of NVAX is 60% BUY, 20% HOLD and 20% SELL.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 62.67% of the time, taking 169.75 days on average.

Highest price target for NVAX is $18, Lowest price target is $8, average price target is $14.5.

Most recent stock forecast was given by GEOFF MEACHAM from CITI on 15-Oct-2026. First documented stock forecast 19-Sep-2014.

Currently out of the existing stock ratings of NVAX, 3 are a BUY (60%), 1 are a HOLD (20%), 1 are a SELL (20%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Sell Since 17-Jun-2025

$8

$0.53 (7.10%)

$6

1 months 6 days ago
(15-Oct-2026)

1/2 (50%)

$-4.82 (-37.60%)

33

Buy Since 28-Aug-2025

$16

$8.53 (114.19%)

$16

7 months ago
(21-Apr-2026)

2/4 (50%)

$7.51 (88.46%)

154

Buy Since 24-Oct-2025

$18

$10.53 (140.96%)

$18

10 months 8 days ago
(12-Jan-2026)

0/2 (0%)

$9.33 (107.61%)

Buy Since 23-Feb-2024

$16

$22

1 years 11 days ago
(10-Nov-2025)

13/39 (33.33%)

$8.89 (125.04%)

100

Hold Since 13-May-2024

$7

$8

1 years 17 days ago
(04-Nov-2025)

3/3 (100%)

$-0.51 (-6.79%)

59

Show more analysts

Please expand the browser size to see the chart

What is NVAX (Novavax) average time for price targets to be met?

On average it took 170 days for the stock forecasts to be reached, with an average price target met ratio of 62.67%.

Which analyst most recently updated their price target on NVAX (Novavax)?

Geoff Meacham

Which analyst has the most public recommendations on NVAX (Novavax)?

Geoff Meacham works at CITI and has 3 price targets and 3 ratings on NVAX

Which analyst is the currently most bullish on NVAX (Novavax)?

Kelechi Chikere with the highest potential upside of $227.53

Which analyst is the currently most reserved on NVAX (Novavax)?

Geoff Meacham with the lowest potential downside of -$2.88
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?